Biohaven Pharmaceutical Holding Company Ltd.
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.36 USD | +1.42% | +1.49% | -72.75% |
04-25 | Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing | MT |
04-23 | Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-72.75% | 541M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- BHVN Stock
- News Biohaven Pharmaceutical Holding Company Ltd.
- JPMorgan Adjusts Price Target on Biohaven Pharmaceutical Holding to $24 From $27, Maintains Overweight Rating